




Searching News Database: fallopian tube
HSMN NewsFeed - 26 May 2020
Elevar Therapeutics Appoints Mark Gelder, M.D. as Global Head of Medical Affairs
Elevar Therapeutics Appoints Mark Gelder, M.D. as Global Head of Medical Affairs
HSMN NewsFeed - 25 Mar 2020
Elevar Therapeutics Acquires Global Rights to European Approved Apealea(R) from Oasmia Pharmaceutical
Elevar Therapeutics Acquires Global Rights to European Approved Apealea(R) from Oasmia Pharmaceutical
HSMN NewsFeed - 22 Jul 2014
FDA Grants Genentech’s Avastin Priority Review for Recurrent Platinum-Resistant Ovarian Cancer
FDA Grants Genentech’s Avastin Priority Review for Recurrent Platinum-Resistant Ovarian Cancer
HSMN NewsFeed - 26 Aug 2013
GeneDx Introduces Advanced Genetic Test Panels for Inherited Cancer Including Breast and Colon Cancer
GeneDx Introduces Advanced Genetic Test Panels for Inherited Cancer Including Breast and Colon Cancer
HSMN NewsFeed - 12 Jun 2013
Amgen Announces Top-Line Results Of Phase 3 Trebananib (AMG 386) TRINOVA-1 Trial In Recurrent Ovarian Cancer
Amgen Announces Top-Line Results Of Phase 3 Trebananib (AMG 386) TRINOVA-1 Trial In Recurrent Ovarian Cancer
HSMN NewsFeed - 30 Apr 2012
Conceptus(R) Announces Settlement of Patent Infringement Lawsuit With Hologic
Conceptus(R) Announces Settlement of Patent Infringement Lawsuit With Hologic
HSMN NewsFeed - 6 Oct 2011
Conceptus(R) Acquires All Distribution Rights Related to the Essure(R) Procedure in the Netherlands
Conceptus(R) Acquires All Distribution Rights Related to the Essure(R) Procedure in the Netherlands
HSMN NewsFeed - 8 Feb 2011
Third Phase III Study of Avastin-Based Regimen Met Primary Endpoint in Ovarian Cancer
Third Phase III Study of Avastin-Based Regimen Met Primary Endpoint in Ovarian Cancer
HSMN NewsFeed - 25 Feb 2010
Genentech Announces Positive Results of Avastin Phase III Study in Women with Advanced Ovarian Cancer
Genentech Announces Positive Results of Avastin Phase III Study in Women with Advanced Ovarian Cancer
HSMN NewsFeed - 28 Jan 2010
Merck Receives European Approval for ELONVA(R) (corifollitropin alfa injection), a New Fertility Treatment
Merck Receives European Approval for ELONVA(R) (corifollitropin alfa injection), a New Fertility Treatment
HSMN NewsFeed - 26 Jan 2010
Two Combination Treatment Regimens Added to Updated NCCN Guidelines for Ovarian Cancer
Two Combination Treatment Regimens Added to Updated NCCN Guidelines for Ovarian Cancer
HSMN NewsFeed - 24 Mar 2009
Myriad Applauds New ACOG Guidelines for Hereditary Breast and Ovarian Cancer
Myriad Applauds New ACOG Guidelines for Hereditary Breast and Ovarian Cancer
HSMN NewsFeed - 13 Dec 2007
FDA Advisory Panel Finds Hologic's Adiana(R) Permanent Contraception Approvable
FDA Advisory Panel Finds Hologic's Adiana(R) Permanent Contraception Approvable
HSMN NewsFeed - 30 Nov 2007
Health Canada Approves Conceptus' Third Generation Essure(R) Permanent Birth Control System
Health Canada Approves Conceptus' Third Generation Essure(R) Permanent Birth Control System
HSMN NewsFeed - 6 Nov 2007
More Than 20 New Studies Show the Many Benefits of Essure(R) Compared with Surgical Tubal Ligation
More Than 20 New Studies Show the Many Benefits of Essure(R) Compared with Surgical Tubal Ligation
HSMN NewsFeed - 29 Oct 2007
European Symposium Focuses on Phenoxodiol as an Investigational Drug for Ovarian Cancer Management
European Symposium Focuses on Phenoxodiol as an Investigational Drug for Ovarian Cancer Management
HSMN NewsFeed - 22 Oct 2007
European Symposium on Phenoxodiol as an Investigational Drug for Ovarian Cancer Management
European Symposium on Phenoxodiol as an Investigational Drug for Ovarian Cancer Management
HSMN NewsFeed - 8 Oct 2007
Immersion Medical Introduces OB/GYN Module for LaparoscopyVR(TM) Surgical Simulator
Immersion Medical Introduces OB/GYN Module for LaparoscopyVR(TM) Surgical Simulator
HSMN NewsFeed - 30 Aug 2007
A Worldwide Phase III Clinical Trial Seeks U.S. Patients to Explore Investigational Drug Phenoxodiol
A Worldwide Phase III Clinical Trial Seeks U.S. Patients to Explore Investigational Drug Phenoxodiol
HSMN NewsFeed - 25 Jul 2007
FDA Approves Conceptus' Third Generation Essure(R) Permanent Birth Control System
FDA Approves Conceptus' Third Generation Essure(R) Permanent Birth Control System
HSMN NewsFeed - 3 Jun 2007
Genentech Provides Update on Pipeline Agents at the American Society of Clinical Oncology Meeting
Genentech Provides Update on Pipeline Agents at the American Society of Clinical Oncology Meeting
HSMN NewsFeed - 20 Oct 2006
Newly Trained ESSURE(R) Physicians Achieve 94.6 Percent Bilateral Placement Success
Newly Trained ESSURE(R) Physicians Achieve 94.6 Percent Bilateral Placement Success
HSMN NewsFeed - 17 Oct 2006
CSMG Technologies Live Tissue Connect Subsidiary Completes Duct and Vessel Sealer Prototype
CSMG Technologies Live Tissue Connect Subsidiary Completes Duct and Vessel Sealer Prototype
HSMN NewsFeed - 12 Sep 2006
Conceptus Announces Partnerships Now in Place with All Major Hysteroscope Manufacturers
Conceptus Announces Partnerships Now in Place with All Major Hysteroscope Manufacturers
Additional items found! 35

Members Archive contains
35 additional stories matching:
fallopian tube
(Password required)
fallopian tube
(Password required)